UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)
<div class="breadcrumb breadcrumbs"><div class="breadcrumb-trail"> » <a href="https://epims.med.ubc.ca" title="UBC PiMS Research Group (the Tremlett Laboratory)" rel="home" class="trail-begin">Home</a> <span class="sep">»</span> <a href="https://epims.med.ubc.ca/category/newsandevents/" rel="tag">News And Events</a>, <a href="https://epims.med.ubc.ca/category/slideshow/" rel="tag">Slideshow</a> <span class="sep">»</span> Interview on Real Talk MS: The MS Prodrome with Dr. Helen Tremlett </div></div>

Interview on Real Talk MS: The MS Prodrome with Dr. Helen Tremlett

Dr. Helen Tremlett was interviewed on MS Talk’s 202nd episode about her presentation on the MS prodrome. Dr. Tremlett co-chaired the virtual workshop, hosted by the MS Society of Canada in partnership with the National MS Society, where she presented. While prodromal Parkinson’s Disease has been recognized and studied since the 80s, in contrast, many textbooks still state that MS is not preceded by early signs and symptoms. Dr. Tremlett discusses her research to objectively measure the MS prodromal phase and what remains to be studied.

Listen to the podcast here.

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia